SEARCH

SEARCH BY CITATION

REFERENCES

  • Boomsma F, Derkx FH, van den Meiracker AH, Man in 't Veld AJ, Schalekamp MA. 1995. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) 88: 675679.
  • Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in 't Veld AJ, Mosterd A, Lie KI, Schalekamp MA. 1997. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33: 387391.
  • Castillo V, Lizcano JM, Visa J, Unzeta M. 1998. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization. Neurochem Int 33: 415423.
  • del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M. 2005. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci Lett. 384: 183187.
  • Enrique-Tarancón G, Marti L, Morin N, Lizcano JM, Unzeta M, Sevilla L, Camps M, Palacín M, Testar X, Carpéné C, Zorzano A. 1998. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J Biol Chem. 1998 273: 80258032
  • Fernandez de Arriba A, Lizcano JM, Balsa D, Unzeta M. 1991. Contribution of different amine oxidases to the metabolism of dopamine in bovine retina. Biochem Pharmacol 42: 23552361.
  • Ferrer I, Lizcano JM, Hernández M, Unzeta M. 2002. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci Lett 321: 2124.
  • Fontana E, Boucher J, Marti L, Lizcano JM, Testar X, Zorzano A, Carpene C. 2001. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells. Biochem J 356: 769777.
  • Garpenstrand H, Ekblom J, von Arbin M, Oreland L, Murray V. 1999. Plasma semicarbazide-sensitive amine oxidase in stroke. Eur Neurol 41: 2023.
  • Grönvall-Nordquist JLE, Bäcklund LB, Garpenstrand H, Ekblom J, Landin B, Yu PH, Oreland L, Rosenqvist U. 2001. Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus. J Diabetes Complications 15: 250256.
  • Jaakkola K, Kaunismäki K, Tohka S, Yegutkin G, Vänttinen E, Havia T, Pelliniemi LJ, Virolainen M, Jalkanen S, Salmi M. 1999. Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 155: 19531965.
  • Jalkanen S, Salmi M. 2001. Cell surface monoamine oxidase: enzymes in search of fuction. Embo J 20: 38933901.
  • Kang P, Svoboda KK. 2005. Epithelial-mesenchymal transformation during craniofacial development. J Dent Res 84: 678690 (review).
  • Karádi I, Mészáros Z, Attila Csányi A, Szombathy T, Hosszúfalusi N, Romics L, Magyar K. 2002. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin Chim Acta 323: 139146.
  • Kaufman MH. 1999. The atlas of mouse development, 3rd revised edition. London: Academic Press Ltd.
  • Kurkijärvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. 2000. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119: 10961010.
  • Lang RA. 1997. Apoptosis in mammalian eye development: lens morphogenesis, vascular regression and immune privilege. Cell Death Differ 4: 1220.
  • Langford SD, Trent MB, Balakumaran A, Boor PJ. 1999. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol 155: 237244.
  • Lewinsohn R. 1984. Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Braz J Med Biol Res 17: 223256 (review).
  • Lizcano JM, Tipton KF, Unzeta M. 1998. Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem J 331: 6978.
  • Lyles GA. 1996. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol. 28: 259274 (review).
  • Lyles GA, Bertie KH. 1987. Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol Toxicol ( Suppl) 1: 33.
  • Mercier N, Osborne-Pellegrin M, El Hadri K, Kakou A, Labat C, Loufrani L, Henrion D, Challande P, Jalkanen S, Fève B, Lacolley P. 2006. Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse. Cardiovas Res 72: 349357.
  • Mészáros Z, Szombathy T, Raimondi L, Karádi I, Romics L, Magyar K. 1999. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48: 113117.
  • Ochiai Y, Itoh K, Sakurai E, Tanaka Y. 2005. Molecular cloning and characterization of rat semicarbazide-sensitive amine oxidase. Biol Pharm Bull 28: 413418.
  • O'Sullivan J, Unzeta M, Healy J, O'Sullivan MI, Davey G, Tipton KF. 2004. Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25: 303315 (review).
  • Otsuka S, Kobayashi Y. 1964. Radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem Pharmacol 13: 9951006.
  • Owens GK, Wise G. 1997. Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors. Agents Actions ( Suppl) 48: 324 (review).
  • Owens GK, Vernon SM, Madsen CS. 1996. Molecular regulation of smooth muscle cell differentiation. J Hypertens ( Suppl) 14: 5564 (review).
  • Pixley SK, Kobayashi Y, de Vellis J. 1984. A monoclonal antibody against vimentin: characterization. Brain Res 317: 185199.
  • Precious E, Gunn CE, Lyles GA. 1988. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol. 37: 707713.
  • Salmi M, Jalkanen S. 1992. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 4: 14071409.
  • Salmi M, Jalkanen S. 2006. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. Blood 108: 15551561.
  • Salmi M, Kalimo K, Jalkanen S. 1993. Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 178: 22552260.
  • Solé M, Hernandez M, Boada M, Unzeta M. 2007. Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J Neural Transm 114: 763767.
  • Souto RP, Vallega G, Wharton J, Vinten J, Tranum-Jensen J, Pilch PF. 2003. Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling. J Biol Chem 278: 1832118329.
  • Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. 1998. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188: 1727.
  • Valente T, Junyent F, Auladell C. 2005. Zac1 is expressed in progenitor/stem cells of the neuroectoderm and mesoderm during embryogenesis: differential phenotype of the Zac1-expressing cells during development. Dev Dyn 233: 667679.
  • Van Muijen GN, Ruiter DJ, Warnaar SO. 1987. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest 57: 359369.
  • Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, Wersto RP, Boheler KR, Wobus AM. 2004. Nestin expression: a property of multi-lineage progenitor cells? Cell Mol Life Sci 61: 25102522 (review).